ADC Therapeutics ADCT
NYSE ADCT
$1.25 +0.02 (+2.03%)
As of: Sep 30, 2026 · 2:04 PM EDT

ADC Therapeutics SA (ADCT) Capital Expenditures (2020 - 2026)

Updated

ADC Therapeutics (ADCT) reported Capital Expenditures of $32,000 for Q1 2026, down 87.9% from $264,000 a year earlier.

Analysis

ADC Therapeutics SA (ADCT) Capital Expenditures (2020 - 2026) Analysis & Trends

For FY2025, ADC Therapeutics posted Capital Expenditures of $264,000, down 69.6% from FY2024.

  • Capital Expenditures has a five-year compound annual growth rate of -19.9% (FY2020 to FY2025).
  • By year, Capital Expenditures came in at $867,000 in FY2024 (-73.0%), $3.22 million in FY2023 (+368.1%), $687,000 in FY2022 (-80.0%) and $3.43 million in FY2021 (+328.2%).
  • The Q1 2026 figure ranks as the lowest quarterly Capital Expenditures since Q2 2024.
  • The high point for year-over-year Capital Expenditures in five years was Q2 2021 (growth of 658.4%); the low point was Q2 2024 (a decline of 97.5%).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 32,000.00
Mar 31, 2025 264,000.00
Dec 31, 2024 90,000.00
Sep 30, 2024 216,000.00
Jun 30, 2024 30,000.00
Mar 31, 2024 531,000.00
Dec 31, 2023 327,000.00
Sep 30, 2023 661,000.00
Jun 30, 2023 1.21 Mn
Mar 31, 2023 1.02 Mn
Dec 31, 2022 214,000.00
Sep 30, 2022 194,000.00
Jun 30, 2022 50,000.00
Mar 31, 2022 229,000.00
Dec 31, 2021 420,000.00
Sep 30, 2021 1.41 Mn
Jun 30, 2021 948,000.00
Mar 31, 2021 657,000.00
Dec 31, 2020 174,000.00
Sep 30, 2020 401,000.00
API Access

ADC Therapeutics SA Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ADCT&period=max&api_key=YOUR_API_KEY